Evaluating the total costs of cancer: The Northwestern University costs of Cancer Program

ONCOLOGY

Volumn 17, Issue 1, 2003, Pages 109-114

  Calhoun, Elizabeth A ^a   Bennett, Charles L ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST OF ILLNESS; ECONOMICS; EPIDEMIOLOGY; HEALTH CARE COST; HEALTH SERVICE; HUMAN; NEOPLASM; PILOT STUDY; STATISTICS; UTILIZATION REVIEW;

COST OF ILLNESS; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HEALTH SERVICES; HUMANS; NEOPLASMS; PILOT PROJECTS;

EID: 0037269507     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. American Cancer Society Facts & Figures. Atlanta, American Cancer Society, 2002.
2. Bozzette SA, Hays RD, Berry SH, et al: A Perceived Health Index for use in persons with advanced HIV disease: Derivation, reliability, and validity. Med Care 32:716-731, 1994.
3. Pascal A, Cvitanic MA, Bennett CL, et al: State policies and the financing of AIDS care. RAND Notes. N-2942-UCFA, 1989.
4. The Ryan White Comprehensive AIDS Resources Emergency (Care) Act. U.S. Department of Human and Health Services web site. Available at http://www.hhs.gov/nerws/press/ 1998pres/981218d.html. Accessed November 11, 2002.
5. Boyer M: The economics of lung cancer. Lung Cancer. 14:13-17, 1996.
6. Statistical the United States 1999, 119th ed. US Department of Commerce Economics and Statistics Administration, US Census Bureau.
7. Waters TM, Weinberg PD, Bennett CL: Health economics in the treatment of colorectal cancer. Cancer Invest 16:582-587, 1998.
8. Phan LT, Lee JU, Calhoun EA, et al: An updated look at the societal cost of toxicity management and out-of-pocket costs for patients and their caregivers (abstract). Proc Am Soc Clin Oncol 21:254a, 2002.
9. Hounshell J, Tomori C, Newlin R, et al: Changes in finances, insurance, employment, and lifestyle among persons diagnosed with hairy cell leukemia. Oncologist 6:435-440, 2001.
10. Calhoun EA, Chang CH, Welshman EE, et al: Evaluating the total costs of chemotherapy-induced toxicity: Results from a pilot study with ovarian cancer patients. Oncologist 6:441-445, 2001.
11. Red Book. Medical Economics Co, Inc, Montvale, NJ, 1999.
12. Bennett CL, Stinson TJ, Vogel V, et al: Evaluating the financial impact of clinical trials in oncology: Results from a pilot study from the Association of American Cancer Institutes/Northwestern University Clinical Trials Costs and Charges Project. J Clin Oncol 18:2805-2810, 2000.